Xilio Therapeutics, Inc.

NASDAQ:XLO

0.7559 (USD) • At close April 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -58.241-76.404-88.222-75.8-55.219-17.311
Depreciation & Amortization 1.6441.91.8471.4991.0650.24
Deferred Income Tax 02.06300.2220.126-1.737
Stock Based Compensation 6.4347.3828.4244.9581.2960.112
Change In Working Capital 31.7820.4052.004-11.80316.6020.797
Accounts Receivables 000000
Inventory 000000
Accounts Payables 1.526-2.0630.485-2.8182.9260.97
Other Working Capital 30.2562.4681.519-8.98513.676-0.173
Other Non Cash Items 0.003-3.9660.2240.1730.0390.056
Operating Cash Flow -18.378-68.62-75.723-80.751-36.091-17.843
Investing Activities:
Investments In Property Plant And Equipment -0.036-0.486-1.867-1.1-2.188-0.715
Acquisitions Net 000000
Purchases Of Investments 000000
Sales Maturities Of Investments 000000
Other Investing Activites 000000
Investing Cash Flow -0.036-0.486-1.867-1.1-2.188-0.715
Financing Activities:
Debt Repayment -3.382-6.752-0.085-0.11-0.0999.952
Common Stock Issued 6.8250.2020.016116.35910.1280
Common Stock Repurchased 00.1940000
Dividends Paid 000000
Other Financing Activities 25.7530.2020.016144.41910.12840.116
Financing Cash Flow 29.196-6.55-0.069260.66810.02960.02
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 10.782-75.656-77.659178.817-28.2541.462
Cash At End Of Period 57.0730.046121.947199.60620.78949.039